Skip to content

Drug interactions

Lidocaine + Olaparib

Severity: Minor

Lidocaine and Olaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olaparib is metabolized by CYP3A4, and moderate or strong inhibitors raise its exposure. Lidocaine is only a weak inhibitor, so a clinically significant increase is unlikely.

What this interaction means in plain words

Lidocaine and Olaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lidocaine belongs to Cardiovascular; Olaparib belongs to Oncology.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by lidocaine may slightly reduce olaparib metabolism.

What to do

No dose change is needed; monitor for olaparib hematologic toxicity as part of routine care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lidocaine and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lidocaine with Olaparib?

MediHelp rates the interaction as minor. Lidocaine and Olaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Olaparib is metabolized by CYP3A4, and moderate or strong inhibitors raise its exposure. Lidocaine is only a weak inhibitor, so a clinically significant increase is unlikely.

How serious is the interaction between Lidocaine and Olaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor for olaparib hematologic toxicity as part of routine care.

What other medicines interact with Lidocaine?

MediHelp also lists interactions of Lidocaine with, for example, Bupivacaine liposome, Disopyramide, Ex vivo expanded autologous human corneal epithelial cells containing stem cells. The full list is on the Lidocaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in